174 related articles for article (PubMed ID: 23101592)
21. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
[TBL] [Abstract][Full Text] [Related]
22. A new method for FMR1 gene methylation screening by multiplex methylation-specific real-time polymerase chain reaction.
Elias MH; Ankathil R; Salmi AR; Sudhikaran W; Limprasert P; Zilfalil BA
Genet Test Mol Biomarkers; 2011 Jun; 15(6):387-93. PubMed ID: 21329465
[TBL] [Abstract][Full Text] [Related]
23. Fragile X syndrome.
Saldarriaga W; Tassone F; González-Teshima LY; Forero-Forero JV; Ayala-Zapata S; Hagerman R
Colomb Med (Cali); 2014; 45(4):190-8. PubMed ID: 25767309
[TBL] [Abstract][Full Text] [Related]
24. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.
Tassone F; Pan R; Amiri K; Taylor AK; Hagerman PJ
J Mol Diagn; 2008 Jan; 10(1):43-9. PubMed ID: 18165273
[TBL] [Abstract][Full Text] [Related]
25. A methylation PCR approach for detection of fragile X syndrome.
Panagopoulos I; Lassen C; Kristoffersson U; Aman P
Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review.
Essop FB; Krause A
S Afr Med J; 2013 Oct; 103(12 Suppl 1):994-8. PubMed ID: 24300646
[TBL] [Abstract][Full Text] [Related]
27. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
28. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
[TBL] [Abstract][Full Text] [Related]
29. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
[TBL] [Abstract][Full Text] [Related]
30. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males.
Santos CB; Costa Lima MA; Pimentel MM
Hum Mutat; 2001 Aug; 18(2):157-62. PubMed ID: 11462240
[TBL] [Abstract][Full Text] [Related]
31. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.
Godler DE; Tassone F; Loesch DZ; Taylor AK; Gehling F; Hagerman RJ; Burgess T; Ganesamoorthy D; Hennerich D; Gordon L; Evans A; Choo KH; Slater HR
Hum Mol Genet; 2010 Apr; 19(8):1618-32. PubMed ID: 20118148
[TBL] [Abstract][Full Text] [Related]
32. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.
Filipovic-Sadic S; Sah S; Chen L; Krosting J; Sekinger E; Zhang W; Hagerman PJ; Stenzel TT; Hadd AG; Latham GJ; Tassone F
Clin Chem; 2010 Mar; 56(3):399-408. PubMed ID: 20056738
[TBL] [Abstract][Full Text] [Related]
33. Maternal FMR1 alleles expansion in newborns during transmission: a prospective cohort study.
Shahid R; Yasin M; Rehman ZU; Jadoon H; Tahir H; Meraj N; Khan N; Zubair M; Zulfiqar I; Nowshid M; Azeem A; Jabeen M; Hameed A; Saleha S
Pediatr Res; 2023 Feb; 93(3):720-724. PubMed ID: 35681093
[TBL] [Abstract][Full Text] [Related]
34. Significantly Elevated
Field M; Dudding-Byth T; Arpone M; Baker EK; Aliaga SM; Rogers C; Hickerton C; Francis D; Phelan DG; Palmer EE; Amor DJ; Slater H; Bretherton L; Ling L; Godler DE
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405222
[TBL] [Abstract][Full Text] [Related]
35. Molecular screening for fragile X syndrome in Thailand.
Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
[TBL] [Abstract][Full Text] [Related]
36. High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.
Chen L; Hadd A; Sah S; Houghton JF; Filipovic-Sadic S; Zhang W; Hagerman PJ; Tassone F; Latham GJ
Genet Med; 2011 Jun; 13(6):528-538. PubMed ID: 21430544
[TBL] [Abstract][Full Text] [Related]
37. [Molecular diagnosis of fragile X syndrome with polymerase chain reaction: application of a diagnostic protocol in 50 families from northern Spain].
Durán Domínguez M; Molina Carrillo M; Fernández Toral J; Martínez Merino T; López Arístegui MA; Alvarez Retuerto AI; Onaindía Urquijo ML; Tejada Mínguez MI
An Esp Pediatr; 2001 Apr; 54(4):331-9. PubMed ID: 11273816
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel epigenetic marker for typical and mosaic presentations of Fragile X syndrome.
da Silva CP; Camuzi D; Reis AHO; Gonçalves AP; Dos Santos JM; Machado FB; Medina-Acosta E; Soares-Lima SC; Santos-Rebouças CB
Expert Rev Mol Diagn; 2023; 23(12):1273-1281. PubMed ID: 37970883
[TBL] [Abstract][Full Text] [Related]
39. Screening for fragile X syndrome among Brazilian mentally retarded male patients using PCR from buccal cell DNA.
Christofolini DM; Lipay MV; Ramos MA; Brunoni D; Melaragno MI
Genet Mol Res; 2006 Jul; 5(3):448-53. PubMed ID: 17117359
[TBL] [Abstract][Full Text] [Related]
40. Repeat expansion and methylation-sensitive triplet-primed polymerase chain reaction for fragile X mental retardation 1 gene screening in institutionalised intellectually disabled individuals.
Sihombing NRB; Cai S; Wong DPW; Guan M; Chong SS; Faradz SMH; Winarni TI
Singapore Med J; 2021 Mar; 62(3):143-148. PubMed ID: 31989181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
